BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 7 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 7 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 7 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 8 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 8 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 9 hours ago Atmus Welcomes Heath Sharp to Board of Directors 11 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 11 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT
Market News

Stryker (SYK): Q3 2019 Earnings Snapshot

— Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected. — Total revenue grew 10.6% to $3.58 billion, in line with the street estimate. Organic sale grew 8.6% in Q3. Orthopaedics net sales of $1.3 billion increased 7.8% YoY. — 2019 organic net sales growth expected near the […]

$SYK October 29, 2019 1 min read

— Stryker (NYSE: SYK) reported third-quarter 2019 earnings of $1.91 per share, vs. $1.90 per share expected.

— Total revenue grew 10.6% to $3.58 billion, in line with the street estimate. Organic sale grew 8.6% in Q3. Orthopaedics net sales of $1.3 billion increased 7.8% YoY.

— 2019 organic net sales growth expected near the higher end of the outlook range of 7.5% to 8.0%.

— Adjusted EPS for 2019 expected in the range of $8.20 to $8.25, and for the fourth quarter between $2.43 and $2.48.

— SYK shares have gained 43% since the beginning of this year.

ADVERTISEMENT

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT